Cosmetic UK updates July 2023
New Cosmetic Regulations in the UK and EU: How AF Pharma Can Help as UKRP
In the ever-evolving landscape of cosmetic regulations, staying informed and compliant is essential for beauty brands looking to enter or continue operating in the UK and European Union markets. Since the Brexit transition, the United Kingdom has been aligning its cosmetic ingredient bans and restrictions with those of the European Union, with a slight delay. A recent development in this realm is the introduction of new restrictions on certain cosmetic substances, as outlined in the Cosmetic Products (Restriction of Chemical Substances) Regulations 2023. In this article, we'll explore the changes in cosmetic regulations and how AF Pharma can be your trusted partner in navigating these regulatory shifts.
Harmonizing Cosmetic Regulations
Post-Brexit, the UK has made significant strides in harmonizing its cosmetic regulations with those of the EU. A key player in this alignment is the Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products (SAG-CS), which evaluates the safety of cosmetic substances. This body closely resembles the European Union's Scientific Committee on Consumer Safety (SCCS) and provides valuable insights that guide the establishment of new restrictions in the UK.
Recent Regulatory Changes
In the third quarter of 2022, the SAG-CS issued its final opinions on three cosmetic substances: Methyl-N-methylanthranilate (M-N-MA), Piperazine (nano), and Piperazine. These opinions paved the way for the Cosmetic Products (Restriction of Chemical Substances) Regulations 2023, which introduced several important updates.
Piperazine and Piperazine (nano) Usage: As of July 28, 2023, cosmetic products in the UK can use Piperazine and Piperazine (nano) as UV filters, provided their concentration does not exceed 10%. This restriction extends to combinations of these substances, where the total sum of concentrations remains within 10%. Notably, additional requirements have been outlined for Piperazine in nano form.
Methyl-N-methylanthranilate (M-N-MA) Restrictions: M-N-MA has been added to the list of restricted substances. It is permissible in leave-on products at a concentration of up to 0.1% and in rinse-off products at a concentration of up to 0.2%. These restrictions aim to ensure consumer safety and product quality.
Compliance Timeline
Beauty brands operating in the UK market have until July 6, 2024, to ensure that their cosmetic products align with the new restrictions. After this date, non-compliant products must either be removed from the market or recalled by July 6, 2026.
Partnering with AF Pharma for Regulatory Success
In the face of evolving cosmetic regulations, having a reliable regulatory partner is crucial. AF Pharma, with its extensive experience in the regulatory sector, stands out as a valuable resource for brands seeking seamless compliance. For over the years, AF Pharma has been offering representative and consultancy services, helping businesses navigate complex regulatory landscapes.
AF Pharma's team of experts is dedicated to supporting your compliance journey. Whether you're a well-established brand or a newcomer in the industry, AF Pharma's comprehensive range of cosmetic services ensures that your products meet regulatory standards and gain access to the UK market without encountering obstacles.
Conclusion
As the UK and EU continue to harmonize their cosmetic regulations, businesses must stay proactive in adapting to new restrictions. The introduction of the Cosmetic Products (Restriction of Chemical Substances) Regulations 2023 underscores the importance of compliance and consumer safety. AF Pharma's unwavering commitment to regulatory excellence positions them as a trustworthy partner for brands looking to navigate these changes successfully. With AF Pharma by your side, you can confidently bring your cosmetic products to the UK market while adhering to the latest regulatory requirements.
For more information on how AF Pharma can assist your business in achieving regulatory compliance and market entry, visit their website and get in touch with their dedicated team.
Also refer to the following links:
https://www.afpharmaservice.com/medical-device/cosmetic-registration-in-europe
https://www.afpharmaservice.com/medical-device/product-information-file-for-cosmetics
https://www.afpharmaservice.com/medical-device/fda-mocra
References:
1. gov.uk. (2023). Scientific Advisory Group on Chemical Safety in Consumer Products. Retrieved on 20.07.2023
2. gov.uk. (2023). The Cosmetic Products (Restriction of Chemical Substances) Regulations 2023. Retrieved on 20.07.2023